Following COVID-19 vaccination, most patients with MS do not face an increased risk for relapse requiring corticosteroid therapy.

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

A mailed knowledge mobilization and behavior change intervention can reduce the use of sedatives and improve sleep outcomes in older adults with insomnia.

For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes.

Policy interventions to mitigate heat-related illness are needed based on the relationship between high HVI and severe stroke.

Parathyroidectomy vs nonoperative management was not associated with a reduced risk for depression among patients with hyperparathyroidism.

Ketamine treatment among patients with fibromyalgia may offer short-term pain relief, though its long-term efficacy and safety remain uncertain.

Frailty is an independent risk factor for increased rates of readmission and inpatient mortality among hospitalized patients with SLE.